• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
David Z. Morris

Stay informed with David Z. Morris’s coverage and analysis.

One billion COVID vaccines
Newsletters
The last mile of the immunization campaign approaches
By Sy Mukherjee and David Z. MorrisApril 23, 2021
Shawmut Facility
Politics
COVID exposed global supply-chain flaws. Can Biden bring manufacturing back to the U.S.?
By David Z. MorrisApril 23, 2021
Skeptical of outdoor masking? Congratulations on catching up to reality.
Newsletters
Skeptical of outdoor masking? Congratulations on catching up to reality.
By Sy Mukherjee and David Z. MorrisApril 22, 2021
The last mile of the immunization campaign approaches
Newsletters
The last mile of the immunization campaign approaches
By Sy Mukherjee and David Z. MorrisApril 21, 2021
Is the Bitcoin bull run over?
Newsletters
Is the Bitcoin bull run over?
By David Z. Morris and Robert HackettApril 21, 2021
What’s the matter with Michigan?
Newsletters
What’s the matter with Michigan?
By Sy Mukherjee and David Z. MorrisApril 20, 2021
A milestone for COVID vaccinations as all U.S. adults are eligible
Newsletters
A milestone for COVID vaccinations as all U.S. adults are eligible
By Sy Mukherjee and David Z. MorrisApril 19, 2021
Drug development innovation
Newsletters
What makes a drug company truly innovative?
By Sy Mukherjee and David Z. MorrisApril 16, 2021
Johnson & Johnson: The pause heard ’round the world
Newsletters
Johnson & Johnson: The pause heard ’round the world
By David Z. Morris and Sy MukherjeeApril 15, 2021
Catalent COVID vaccine contract manufacturers
Newsletters
The crucial third party players in the pandemic fight
By David Z. Morris and Sy MukherjeeApril 14, 2021
Maybe Coinbase is hard to value because it’s a ‘hyperobject’
Newsletters
Maybe Coinbase is hard to value because it’s a ‘hyperobject’
By David Z. Morris and Robert HackettApril 14, 2021
An abundance of caution with the Johnson & Johnson vaccine
Newsletters
An abundance of caution with the Johnson & Johnson vaccine
By David Z. Morris and Sy MukherjeeApril 13, 2021
You just got the J&J COVID vaccine. Should you be worried about the CDC’s pause recommendation?
Health
You just got the J&J COVID vaccine. Should you be worried about the CDC’s pause recommendation?
By David Z. MorrisApril 13, 2021
Mastercard, UBS, and JPMorgan pour $65 million into Ethereum startup studio ConsenSys
The Coins
Mastercard, UBS, and JPMorgan pour $65 million into Ethereum startup studio ConsenSys
By David Z. MorrisApril 13, 2021
The public health scourge we don’t talk about nearly enough
Newsletters
The public health scourge we don’t talk about nearly enough
By David Z. Morris and Sy MukherjeeApril 9, 2021
1
  • 1
  • 2
  • 3
  • 4
  • 5
...100
Most Popular
Success
Jensen Huang says ‘a lot’ of six-figure jobs in plumbing and construction will soon be unlocked because someone needs to build new AI centersplaceholder alt text
By Preston ForeAugust 1, 2026
Personal Finance
Millennials say they’ll refuse to care for aging boomer parents—but they’ll be forced to as their inheritance shrinks to 40 cents on the dollarplaceholder alt text
By Nick LichtenbergJuly 31, 2026
Retail
The rise of 'conspicuous waiting': The 19th-century economic theory that explains why Gen Z posts their place in lineplaceholder alt text
By Tatiana SatauaJuly 31, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.